标题
Treating osteoporosis to prevent fractures: current concepts and future developments
作者
关键词
-
出版物
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-01-18
DOI
10.1111/joim.12873
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: The Rotterdam Study
- (2018) Katerina Trajanoska et al. BONE
- Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome
- (2018) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
- (2018) Lee Shepstone et al. LANCET
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Adverse effects of media reports on the treatment of osteoporosis
- (2018) Cristiana Cipriani et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Rates of osteoporosis screening and treatment following vertebral fracture
- (2018) David W. Barton et al. Spine Journal
- Fracture Prevention with Zoledronate in Older Women with Osteopenia
- (2018) Ian R. Reid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Related Adverse Events of Osteoporosis Therapy
- (2017) Moin Khan et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation
- (2017) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis
- (2017) Ya-Kang Wang et al. MEDICINE
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women
- (2017) Lisa Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Observations following discontinuation of long-term denosumab therapy
- (2017) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Hip fracture trends in the United States, 2002 to 2015
- (2017) E. Michael Lewiecki et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- UK clinical guideline for the prevention and treatment of osteoporosis
- (2017) J. Compston et al. Archives of Osteoporosis
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture
- (2016) Seoyoung C Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postmenopausal Osteoporosis
- (2016) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of a minimal resource fracture liaison service
- (2016) K. F. Axelsson et al. OSTEOPOROSIS INTERNATIONAL
- Imminent risk of fracture after fracture
- (2016) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
- (2016) Bo Abrahamsen et al. BMJ-British Medical Journal
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
- (2016) Bo Abrahamsen et al. BMJ-British Medical Journal
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoporosis: the evolution of a diagnosis
- (2015) M. Lorentzon et al. JOURNAL OF INTERNAL MEDICINE
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
- (2015) M. M. Bonafede et al. OSTEOPOROSIS INTERNATIONAL
- Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015
- (2015) A. Khan et al. OSTEOPOROSIS INTERNATIONAL
- Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures
- (2014) Carolyn J. Crandall et al. ANNALS OF INTERNAL MEDICINE
- The Potential Economic Benefits of Improved Postfracture Care: A Cost-Effectiveness Analysis of a Fracture Liaison Service in the US Health-Care System
- (2014) Daniel H Solomon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
- (2014) Daniel H Solomon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- New bone-forming treatments for osteoporosis
- (2014) Socrates E. Papapoulos Nature Reviews Endocrinology
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
- (2013) Patrick Haentjens ANNALS OF INTERNAL MEDICINE
- Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis
- (2013) Lydia Gedmintas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams
- (2013) I. R. Reid et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
- (2013) J. Compston et al. MATURITAS
- Incidence and demography of femur fractures with and without atypical features
- (2012) Adrianne C Feldstein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
- (2012) Roland Baron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis
- (2012) K. Ganda et al. OSTEOPOROSIS INTERNATIONAL
- Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
- (2011) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision
- (2011) A. R. McLellan et al. OSTEOPOROSIS INTERNATIONAL
- Sclerostin: Current Knowledge and Future Perspectives
- (2010) M. J. C. Moester et al. CALCIFIED TISSUE INTERNATIONAL
- Skeletal disease in primary hyperparathyroidism
- (2010) Shonni J. Silverberg et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FRAX® and its applications to clinical practice
- (2009) John A. Kanis et al. BONE
- Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
- (2009) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical subsequent fractures cluster in time after first fractures
- (2008) T A C M van Geel et al. ANNALS OF THE RHEUMATIC DISEASES
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate
- (2008) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
- (2007) Steven Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search